ASX, ACHC and BLKB have been added to the Zacks Rank #5 (Strong Sell) List on March 27, 2025.
ASX, ACHC and GOLD have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2025.
ASTS, ACHC and ASX have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2025.
AMCX, ACHC and ADV have been added to the Zacks Rank #5 (Strong Sell) List on March 19, 2025.
ACHC, TDW and RMR have been added to the Zacks Rank #5 (Strong Sell) List on March 5, 2025.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q4 2024 Earnings Conference Call February 28, 2025 9:00 AM ET Company Participants Patrick Feeley - Senior Vice President of Investor Relations Christopher Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners Brian Tanquilut - Jefferies A.J. Rice - UBS Ben Hendrix - RBC Capital Markets John Ransom - Raymond James Matthew Gillmor - KeyBanc Capital Markets Scott Fidel - Stephens Andrew Mok - Barclays Operator Hello, and welcome to the Acadia Healthcare Fourth Quarter 2024 Earnings Conference Call.
ACHC expects revenues to be between $3.3 billion and $3.4 billion in 2025.
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.64 per share, missing the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.85 per share a year ago.
ACHC's fourth-quarter earnings are likely to have benefited from growing patient days and admissions.
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends.
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.